Syncona Portfolio Ltd 13D and 13G filings for Achilles Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 6:40 pm Unchanged | 2023-12-31 | 13G | Achilles Therapeutics plc ACHL | Syncona Portfolio Ltd | 11,086,909 27.200% | 0 (Unchanged) | Filing |
| 2022-02-11 12:22 pm Purchase | 2021-12-31 | 13G | Achilles Therapeutics plc ACHL | Syncona Portfolio Ltd | 11,086,909 27.300% | 11,086,909 (New Position) | Filing |